Prostate cancer differentiation, DiaPat PCa status test

850.00 €

umsatzsteuerbefreit nach §4 Nr.14a UStG plus delivery
In stock
Delivery time: 2-3 day(s)

Description

PCa status test

About 45% of patients initially diagnosed with prostate cancer have only a slow-growing form of cancer. In this case, 'active surveillance' is a good idea, so that only patients with aggressive prostate cancer can be operated on. However, this means that biopsies are always necessary. The DiaPat® PCa Status test helps to avoid frequent, invasive biopsies and to detect malignant prostate cancer with high accuracy.



  • Active surveillance of prostate cancer
  • Collect urine sample - simple + discreet
  • CE-compliant laboratory diagnostics
  • High analytical accuracy
  • Clinically proven
  • Result within 2-3 working days after sample receipt